Risk factors

Xcel Energy faces new pressures from rising AI-driven cybersecurity threats and surging data center power demands. Wildfire risks and PHMSA natural gas pipeline compliance rules received heightened scrutiny. Cost recovery challenges intensified amid customer affordability pressures.

Xencor expanded disclosures regarding international clinical trials, geopolitical risks involving China-based manufacturers, and potential regulatory or government shutdown delays.

Xylem faces increasing operational risks from complex global supply chains and geopolitical tensions in regions like China, Taiwan, and Mexico. Sustainability and climate targets introduce new compliance, reporting, and financial hurdles. The company continues to prioritize large project execution, R&D, and cost-restructuring initiatives.

Clear Secure highlights new risks concerning M&A integration hurdles, third-party intellectual property licensing, and the Inflation Reduction Act excise tax on share buybacks.

Net losses deepened to $33.0 million and accumulated deficit reached $76.6 million in 2025.

No risk-factor additions, removals, or rewordings were identified.

The FDA may require U.S. bridging studies or repeat trials before ABCL635 and ABCL575 can start planned Phase 3 trials.

Illinois, New Mexico and Texas generated 65.3% of 2025 net service revenues, with Illinois alone accounting for 37.0%.

Power segment customer concentration rose: two customers generated more than 30% of 2025 segment revenue, versus one customer above 10% in 2024.

New risks emphasize climate impacts, MLS and partner access, AI use, agent recruitment, and strategic transactions.

Newly identified risks include losses on capitated care contracts if patient-care costs exceed fixed payments and Medicare policy changes affecting CGM revenue.

A new post-separation plan targets operating-model, technology, AI, automation and real-estate changes, with about $65 million in costs.